A review of therapeutics targeting excitotoxicity in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects between 14,000 to 15,000 Americans. The upper and lower motor neurons degenerate, which eventually causes muscle paralysis, atrophy, and ultimately death from respiratory failure. It has a high treatment cost...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/36171 |